Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DONANEMAB-AZBT for Cognitive disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 96 adverse event reports in the FDA FAERS database where DONANEMAB-AZBT was used for Cognitive disorder.

Most Reported Side Effects for DONANEMAB-AZBT

Side Effect Reports % Deaths Hosp.
Amyloid related imaging abnormality-oedema/effusion 185 18.2% 2 20
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits 139 13.7% 1 12
Headache 111 10.9% 1 16
Infusion related reaction 97 9.5% 1 11
Amyloid related imaging abnormalities 80 7.9% 4 13
Flushing 68 6.7% 0 7
Cerebral haemorrhage 54 5.3% 4 14
Dizziness 48 4.7% 1 9
Nausea 44 4.3% 0 4
Cerebral microhaemorrhage 41 4.0% 0 1
Confusional state 40 3.9% 1 9
Dyspnoea 39 3.8% 0 8
Chills 38 3.7% 0 4
Erythema 34 3.3% 0 4
Blood pressure increased 33 3.2% 0 6

Other Indications for DONANEMAB-AZBT

Product used for unknown indication (603) Dementia alzheimer's type (347) Dementia (25)

Other Drugs Used for Cognitive disorder

DONEPEZIL (350) LECANEMAB-IRMB (282) QUETIAPINE (141) RIVASTIGMINE (137) MEMANTINE (135) RISPERIDONE (112) PIMAVANSERIN (92) DALFAMPRIDINE (59) CLOZAPINE (47) OLANZAPINE (43)

Related Pages

DONANEMAB-AZBT Full Profile All Cognitive disorder Drugs DONANEMAB-AZBT Demographics DONANEMAB-AZBT Timeline